Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP [1]
      • PEP4LEP project
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Glucocorticoids in Leprosy Reversal reaction

Yuniati R, Khrisna MB. Walter de Gruyter GmbH. Serbian Journal of Dermatology and Venereology. 2019; 11 (3) : 77-83.
Download PDF
Publication

Temporal trend of leprosy among the elderly in Brazil, 2001 - 2018.

Rocha M, Nobre M, Garcia LP. Revista panamericana de salud publica = Pan American journal of public health. 2020;
Download PDF
Publication

Management Non-healing Trophic Ulcer in a Leprosy Patient with Combination of Injection and Topical Platelet Rich Plasma

Suryawati N, Praharsini I, Juliyanti J. Journal skin stem cell. 2020;
Download PDF
Publication

Hanseníase e carência social: definição de áreas prioritárias em estado endêmico do Nordeste brasileiro

Souza CDF, Magalhães MAFM, Luna CF. FapUNIFESP (SciELO). Revista Brasileira de Epidemiologia. 2020;
Download PDF
Publication

Rumah Sobat: Integrated Self-Care Group for Leprosy in Jayapura City, Papua Province

Oktavian A, Krismawati H, Arisanti Y, et al. Advances in health sciences research. 2020;
Download PDF
Publication

Metagenomics of Imported Multidrug-Resistant Mycobacterium leprae, Saudi Arabia, 2017.

Guan Q, Almutairi T, Alhalouli T, et al. Emerging infectious diseases. 2020; 26 (3) : 615-617.
Download PDF
Publication

Evidence for Mycobacterium leprae Drug Resistance in a Large Cohort of Leprous Neuropathy Patients from India.

Mahajan N, Lavania M, Singh I, et al. The American journal of tropical medicine and hygiene. 2020;
Publication

The immunology of other mycobacteria: M. ulcerans, M. leprae.

Röltgen K, Pluschke G, Spencer J, et al. Seminars in immunopathology. 2020;
Download PDF
Publication

Family of caregiver-based prevention among leprosy patients in Sampang District

Basri A, Hargono R, Ulfiana E, et al. International journal of nursing and health services. 2019;
Download PDF
Publication

De novo histoid leprosy in an immunocompetent male: a rare case report from North east India

Kalvit K. International journal of scientific report. 2019; 5 (11) : 338-340.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 389
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD